Post-kala-azar dermal leishmaniasis: a global overview
- 7 January 2026
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (5) , 789-804
Abstract
Post-kala-azar dermal leishmaniasis (PKDL) is a chronic dermal sequela in apparently cured patients with visceral leishmaniasis (VL). It presents with either macular or polymorphic forms, and poses a major epidemiological challenge in South Asia, particularly in India, Bangladesh and Nepal. Although nonfatal, PKDL acts as a reservoir for Leishmania donovani, thereby sustaining transmission in the postelimination phase of VL. Potential risk factors for PKDL include a history of VL, immunosuppression, host genetics and malnutrition. The disease burden is further complicated by poor health-seeking behaviour and stigma associated with dermal lesions, leading to diagnostic delays and under-reporting. PKDL is associated with a mixed T helper 1/2 profile, translating into a mixed anti-inflammatory/regulatory and proinflammatory milieu. This is coupled with prominent infiltration of immune cells into lesional sites, including macrophages, lymphocytes and neutrophils, which cause localized immune alteration. The diagnosis of PKDL is challenging in macular cases due to their low parasite burden and overlapping symptoms with other hypopigmentary disorders, but molecular tools now offer improved sensitivity and even have field-level applicability. In terms of therapeutics, the management of PKDL is hindered by the need for prolonged treatment, chances of relapse, emerging drug resistance and noncompliance. Overall, the integration of molecular diagnostics, immunological insights and community-based treatment strategies are essential to eliminate PKDL and sustain efforts to eliminate kala-azar.Keywords
Funding Information
- Indian Council of Medical Research (6/9-7(263) KA/2021/ECD-II)
- Indian Council of Medical Research (JCB/2019/000043)
- Indian Council of Medical Research (INV-048694)
- Indian Council of Medical Research (CfP-NTD2023)
- Council of Scientific and Industrial Research, India
This publication has 105 references indexed in Scilit:
- Road‐map of pre‐clinical treatment for Visceral LeishmaniasisDrug Development Research, 2021
- Advancement in leishmaniasis diagnosis and therapeutics: An updateEuropean Journal of Pharmacology, 2021
- The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasisCytokine, 2021
- Rapid diagnosis of Leishmania infection with a portable loop-mediated isothermal amplification deviceJournal of Biosciences, 2021
- Leishmaniasis: where are we and where are we heading?Parasitology Research, 2021
- Environmental and socioeconomic risk factors associated with visceral and cutaneous leishmaniasis: a systematic reviewParasitology Research, 2020
- Application of loop-mediated isothermal amplification assay for the sensitive and rapid diagnosis of visceral leishmaniasis and post-kala-azar dermal leishmaniasisDiagnostic Microbiology and Infectious Disease, 2013
- Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profileThe Journal of Pathology, 1999
- Identification of Leishmania donovani using a polymerase chain reaction in patient and animal material obtained from an area of endemic kala-azar in the SudanActa Tropica, 1993
- Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatmentTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992